ReShape Lifesciences Inc. (RSLS) Reports Q2 Net Loss of $7.8M

ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q2 net loss of $7.8 million. Revenue for the quarter came in at $2.9 million versus the consensus estimate of $3.41 million.

For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
• Yum! Brands (YUM) PT Lowered to $180 at Argus